Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

After Some Good Luck, Nio Stock Has a Lot to Prove

By Chris Markoch, InvestorPlace Contributor

Up over 300% for the last year, Nio stock has the attention of serious investors. But for the stock to continue to grow, it must prove it can turn a profit.

Smart Money Should Stay Away from Genius Brands

By Chris Markoch, InvestorPlace Contributor

The bullish case for GNUS stock depends on whether you believe young remote learners will opt to fill their downtime with the company's app.

Sorrento Is Stuck In a Story of Its Own Creation

By Chris Markoch, InvestorPlace Contributor

SRNE stock is up over 230% as speculative investors buy the hope that one of its three Covid-19 approaches will latch on. But what if none of them do?

There are Several Reasons to Trust the Medtronic Rally

By Chris Markoch, InvestorPlace Contributor

Medtronic posted falling sales due to a hit in elective procedures. But rising demand and a strong balance sheet will support MDT stock.

Things Get Complicated When Looking At Nikola Stock

By Chris Markoch, InvestorPlace Contributor

The future of Nikola stock is clearly in delivering on the promise of hydrogen. But in the short term, NKLA needs a traditional approach.

Make No Mistake, Danaher Stock Is a Strong Buy

By Chris Markoch, InvestorPlace Contributor

After plummeting in the pandemic selloff, Danaher stock has more than recovered. And when institutional investors return, the stock should move higher..

There’s a Crude Case for Marathon Oil

By Chris Markoch, InvestorPlace Contributor

Unlike oil companies that are going bankrupt, Marathon is sitting on a raft of cash. But for MRO stock to move higher, it needs crude to move higher.

For JetBlue, the More Things Change, the More They Stay the Same

By Chris Markoch, InvestorPlace Contributor

Passengers are flying, but airline executives say they need immediate relief to prevent layoffs. If that's true, there's no reason to buy JBLU stock.

Hold On to General Electric and Hope for the Best

By Chris Markoch, InvestorPlace Contributor

GE stock is stuck in a holding pattern as the novel coronavirus affected each of its business units. Wait until the storm clears to make it a buy.

All Signs Are Signaling that Nvidia is a Buy

By Chris Markoch, InvestorPlace Contributor

Nvidia is getting strong growth from its gaming and data center segments. And that means that NVDA stock is a screaming buy for investors.

Load More